Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Wyeth |
---|---|
Information provided by: | Wyeth |
ClinicalTrials.gov Identifier: | NCT00663065 |
This is study to determine the safety of PAZ-417 in healthy adults over 65.
Condition | Intervention | Phase |
---|---|---|
Healthy |
Drug: PAZ-417 |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Single Group Assignment, Safety Study |
Official Title: | An Ascending Multiple-Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of PAZ-417 Administered Orally to Elderly Subjects |
Estimated Enrollment: | 40 |
Study Start Date: | April 2008 |
Estimated Study Completion Date: | September 2008 |
Estimated Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
arm 1: Experimental | Drug: PAZ-417 |
Ages Eligible for Study: | 65 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion:
Exclusion
Contact: Trial Manager | clintrialparticipation@wyeth.com |
United States, Arizona | |
Recruiting | |
Tempe, Arizona, United States, 85283 |
Study Director: | Medical Monitor | Wyeth |
Responsible Party: | Wyeth ( Wyeth (Registry Contact: Clinical Trial Registry Specialist) ) |
Study ID Numbers: | 3186A1-1102 |
Study First Received: | April 17, 2008 |
Last Updated: | April 19, 2008 |
ClinicalTrials.gov Identifier: | NCT00663065 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Healthy subjects over 65 healthy subjects |
Healthy |